Carcinoembryonic antigen as an adjunct to determination of clinical stage in prostate cancer.
Publication
, Journal Article
Kane, RD; Paulson, DF
Published in: Natl Cancer Inst Monogr
December 1978
CEA level has been measured in a series of prostate cancer patients. Data are presented to show CEA correlation with clinical course and acid phosphatase level.
Duke Scholars
Published In
Natl Cancer Inst Monogr
ISSN
0083-1921
Publication Date
December 1978
Issue
49
Start / End Page
231
Location
United States
Related Subject Headings
- Prostatic Neoplasms
- Male
- Humans
- Diagnostic Errors
- Carcinoembryonic Antigen
- Acid Phosphatase
Citation
APA
Chicago
ICMJE
MLA
NLM
Kane, R. D., & Paulson, D. F. (1978). Carcinoembryonic antigen as an adjunct to determination of clinical stage in prostate cancer. Natl Cancer Inst Monogr, (49), 231.
Kane, R. D., and D. F. Paulson. “Carcinoembryonic antigen as an adjunct to determination of clinical stage in prostate cancer.” Natl Cancer Inst Monogr, no. 49 (December 1978): 231.
Kane RD, Paulson DF. Carcinoembryonic antigen as an adjunct to determination of clinical stage in prostate cancer. Natl Cancer Inst Monogr. 1978 Dec;(49):231.
Kane, R. D., and D. F. Paulson. “Carcinoembryonic antigen as an adjunct to determination of clinical stage in prostate cancer.” Natl Cancer Inst Monogr, no. 49, Dec. 1978, p. 231.
Kane RD, Paulson DF. Carcinoembryonic antigen as an adjunct to determination of clinical stage in prostate cancer. Natl Cancer Inst Monogr. 1978 Dec;(49):231.
Published In
Natl Cancer Inst Monogr
ISSN
0083-1921
Publication Date
December 1978
Issue
49
Start / End Page
231
Location
United States
Related Subject Headings
- Prostatic Neoplasms
- Male
- Humans
- Diagnostic Errors
- Carcinoembryonic Antigen
- Acid Phosphatase